The new US Food and Drug Administration Proposed Rules for pharmaceutical products for the special population of pregnant women were published in May 2008. With these new rules in place, clinicians caring for women who are pregnant may begin to have clearer and more relevant information in the product label to guide clinical decisions regarding drug use during pregnancy.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/j.1542-2011.2011.00067.x | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!